ORIC Pharmaceuticals, Inc. (ORIC)
NASDAQ: ORIC · Real-Time Price · USD
11.81
-0.18 (-1.50%)
Oct 12, 2026, 4:00 PM EDT - Market closed
ORIC Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 16 analysts polled by S&P Global, ORIC Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $21.43. The average 1-year stock price forecast is 81.46% higher than the current stock price, while the lowest is $14 (+18.54%) and the highest is $27 (+128.62%).
Price Target: $21.43 (+81.46%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for ORIC Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 13 | 13 | 12 | 11 | 12 | 13 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 16 | 15 | 14 | 15 | 16 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Buy Initiates $26 | Buy | Initiates | $26 | +120.15% | Sep 23, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $25 → $27 | Buy | Reiterates | $25 → $27 | +128.62% | Aug 10, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains $23 | Buy | Maintains | $23 | +94.75% | Aug 7, 2026 |
| Evercore ISI | Evercore ISI | Buy Maintains $25 | Buy | Maintains | $25 | +111.69% | Aug 4, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $14 | Buy | Maintains | $14 | +18.54% | Aug 4, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.49
from -1.47
EPS Next Year
-1.67
from -1.49
EPS and Forward PE are based on non-GAAP adjusted numbers.